Is Moma Litinib Good for Anemia?

Roxelitna has been in clinical development for a very long period of time. It was compared to ruxolitinib in front line setting, had to have in blinded way, equal control of the spleen,. The symptoms were not as well controlled as was with ruxolitInib. That's why the study failed. Although there was also evidence of a good control of anemia. This is another drug that possibly can improve the anemia through different mode of action. We're going to talk about this a little bit later. But because that study was unsuccessful in control of the symptoms, it was not approved. Further studies were done. Latest study called momentum study was